Anemia News and Research

RSS

Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.

WHO unveils new strategy to fight some of the most neglected tropical diseases

The World Health Organization (WHO) and a group of more than 25 partner organizations unveiled a new strategy to fight some of the most neglected tropical diseases that destroy the lives and health of poor people.

26 Oct 2006

Use of subcutaneous injections of Epogen for dialysis patients could save Medicare $537 million annually

Administering the anti-anemia drug Epogen to kidney dialysis patients by subcutaneous injections rather than intravenously could save the federal government hundreds of millions of dollars annually, the Boston Globe reports.

24 Oct 2006

HRSA to allocate $14M to public umbilical cord blood banks

HHS' Health Resources and Services Administration plans to allocate $14 million to public umbilical cord blood banks nationwide in an effort to increase the supply of cord blood from 50,000 to 150,000 units, the AP/Washington Post reports.

17 Oct 2006

FDA approves Zolinza for the treatment of cutaneous T-cell lymphoma

The U.S. Food and Drug Administration (FDA) has approved Zolinza (vorinostat) capsules for the treatment of cutaneous T-cell lymphoma (CTCL), a type of skin cancer, to be used when the disease persists, gets worse, or comes back during or after treatment with other medicines.

8 Oct 2006

Quality indicators for gastrointestinal endoscopic procedures

Defining measurements and identifying quality standards in the delivery of colonoscopic care is a major priority for the nation's leading gastrointestinal endoscopic healthcare association.

13 Sep 2006

High copayments for 'specialty pharmacy' medications has little effect on use

Higher copayments have a small effect on usage of "specialty pharmacy" medications, which can cost as much as $10,000 monthly, according to a study published Tuesday in the journal Health Affairs, the Pittsburgh Post-Gazette reports.

13 Sep 2006

UIC receives $20 million NCI grant to research blood disorders

A $19.6 million National Cancer Institute grant has been awarded to the University of Illinois at Chicago College of Medicine to advance basic and clinical research for incurable blood disorders.

6 Sep 2006

Allergies may put you more at risk of Parkinson's disease

According to researchers people who suffer from allergic rhinitis may be more at risk for Parkinson's disease later in life.

9 Aug 2006

Allergic rhinitis linked to the development of Parkinson's disease

Researchers from Mayo Clinic have discovered that allergic rhinitis is associated with the development of Parkinson's disease later in life. Findings will be published in the Aug. 8 issue of the journal Neurology.

7 Aug 2006

Older patients with atrial fibrillation have higher rates of major hemorrhage in the brain

Older patients with atrial fibrillation have higher rates of major hemorrhage in the brain whether or not they are using a common blood thinning therapy, according to a new study.

3 Aug 2006

Likelihood of hemorrhage on warfarin is relatively small

Older patients with atrial fibrillation have higher rates of major hemorrhage in the brain whether or not they are using a common blood thinning therapy, according to a new study.

2 Aug 2006

Getting high on mothballs lands teens in hospital

Doctors were mystified when an 18-year-old French woman appeared at a hospital with scaly skin on her legs and hands, and was unsteady and mentally sluggish.

30 Jul 2006

FDA approval for Gemzar for ovarian cancer

Eli Lilly and Company announced that the United States Food and Drug Administration (FDA) has approved Gemzar (gemcitabine HCl) for use in the treatment of women living with recurrent ovarian cancer.

18 Jul 2006

Dog DNA provides clues to combating diseases such as diabetes and multiple sclerosis in humans

Melbourne researchers are examining the DNA of dogs in a research project aiming at determining the genetic causes of common pet diseases - and to provide a model for combating diseases such as diabetes and multiple sclerosis in humans.

5 Jul 2006

FDA grants accelerated approval for Sprycel (dasatinib)

FDA grants accelerated approval for Sprycel (dasatinib), a new oral treatment for patients with chronic myeloid leukemia (CML),

29 Jun 2006

Affymax and Takeda announce agreement for commercialization of Hematide for anemia

Affymax and Takeda Pharmaceutical Company have announced that the companies have entered into an exclusive global agreement to develop and commercialize Affymax's lead product candidate, Hematide, for the treatment of anemia.

27 Jun 2006

Stem-cells may help the body cure itself

Researchers at Karolinska Institutet have identified an important mechanism that regulates how many new cells are produced by each intestinal stem cell.

26 Jun 2006

HIV positive women are much more likely to suffer from anaemia and high blood pressure in pregnancy

The researchers identified a number of key health issues facing HIV positive pregnant women.

19 Jun 2006

Delayed umbilical cord clamping can prevent anemia

Just a two-minute delay in clamping a baby's umbilical cord can boost the child's iron reserves and prevent anemia for months, report nutritionists at the University of California, Davis.

18 Jun 2006

Researchers identify mechanism that regulates how many new cells are produced by each intestinal stem cell

Researchers at Karolinska Institutet have identified an important mechanism that regulates how many new cells are produced by each intestinal stem cell.

18 Jun 2006